2138 — EC Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.41bn
- HK$2.78bn
- HK$3.88bn
- 40
- 86
- 10
- 39
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 450 | 361 | 266 | 321 | 136 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 5.47 | 21.4 | 18.5 | 56.7 | 136 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -279 | -51.3 | 26.5 | -202 | -254 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 238 | 576 | 621 | 608 | 605 |
Capital Expenditures | -287 | -69.8 | -149 | -260 | -412 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 270 | 386 | -220 | -311 | -311 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.1 | 316 | -369 | -571 | -724 |
Financing Cash Flow Items | 34.2 | -14.2 | -26.3 | 197 | -59.4 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -149 | -739 | 157 | -100 | -40.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 71.5 | 153 | 411 | -60.8 | -160 |